Financial Performance - Operating revenue for the period was ¥164,295,406.81, representing a year-on-year increase of 23.32%[6] - Net profit attributable to shareholders was ¥11,213,798.92, up 29.39% from the same period last year[6] - Basic earnings per share rose to ¥0.04, reflecting a 33.33% increase compared to the previous year[6] - Total operating revenue for Q1 2018 was CNY 164,295,406.81, an increase of 23.3% compared to CNY 133,224,729.02 in the same period last year[23] - Net profit for Q1 2018 reached CNY 11,794,753.75, representing a 32.1% increase from CNY 8,922,564.27 in Q1 2017[23] - The company reported a total comprehensive income of CNY 11,501,426.69, an increase from CNY 8,795,546.01 year-over-year[25] Cash Flow and Liquidity - Cash flow from operating activities showed a significant improvement, with a net cash outflow of only ¥47,134.52 compared to a net outflow of ¥9,508,695.20 in the same period last year, a reduction of 99.50%[6] - Cash and cash equivalents decreased to CNY 108,783,943.71 from CNY 179,571,042.51, indicating a decline in liquidity[15] - Cash received from investment activities decreased by 100% to CNY 0, as there were no cash inflows from investment activities this period[11] - The cash outflow for investment activities in Q1 2018 was 89,529,657.76 CNY, compared to 265,077,781.43 CNY in the previous year, indicating a reduction of approximately 66.3%[31] - The ending cash and cash equivalents balance decreased to $46,796,060.61 from $91,897,527.33 year-over-year, showing a decline in liquidity[33] Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,580,268,061.66, an increase of 0.34% compared to the end of the previous year[6] - Total current liabilities decreased to CNY 385,717,605.57 from CNY 484,033,461.18, showing a reduction in short-term financial obligations[17] - Non-current liabilities increased to CNY 241,766,073.16 from CNY 162,593,807.05, indicating a rise in long-term financial commitments[17] - The company's total assets amounted to CNY 1,053,164,560.11, a decrease from CNY 1,119,241,937.50 at the end of the previous period[21] - Total liabilities decreased to CNY 395,145,236.98 from CNY 459,485,375.93, indicating a reduction of approximately 14%[21] Shareholder Information - The number of shareholders at the end of the reporting period was 14,097, with the top ten shareholders holding a combined 69.38% of the shares[9] Tax and Other Income - Tax refunds received increased by 92.19% to CNY 4,896,790.63, primarily due to increased export tax rebates from subsidiary Jimin Tang[11] - Other operating cash receipts rose by 36.75% to CNY 1,491,815.78, attributed to an increase in cash related to other operating activities[11] - Total tax payments increased by 70.84% to CNY 23,544,133.90, mainly due to an overall rise in company tax expenses[11] Borrowings - Short-term borrowings decreased by 38.89% to ¥99,000,000.00, attributed to loan repayments[10] - Long-term borrowings increased by 57.32% to ¥219,191,958.52, mainly due to project loans from subsidiaries[10] Inventory and Operating Costs - The company’s inventory decreased to CNY 47,122,860.52 from CNY 55,287,857.46, reflecting a reduction of approximately 14.5%[20] - Total operating costs for Q1 2018 were CNY 148,328,893.59, up 22% from CNY 121,727,875.63 year-over-year[23]
济民医疗(603222) - 2018 Q1 - 季度财报